Many cell and gene therapies introduce transgenes into target cells utilizing viral and nonviral vectors. The accurate assessment of transduction/ transfection efficiency and the number of vector copies are critical aspects of therapy characterization.
The Tapestri Platform enables multiple genotypic and phenotypic attributes to be co-measured across 1000s of individual cells. This high-throughput platform collapses multiple assays into one workflow, accelerating CMC programs from preclinical analysis to product characterization, and can be adapted for lot release testing.
